Zobrazeno 1 - 10
of 165
pro vyhledávání: '"H.M. Vriesendorp"'
Autor:
H.M. Vriesendorp, Peter J. Heidt
Publikováno v:
Experimental hematology. 44(8)
Nuclear warfare at the end of World War II inspired Dick W. van Bekkum to study total-body irradiation (TBI) in animal models. After high-dose TBI, mice died from "primary disease" or bone marrow (BM) aplasia. Intravenous administration of allogeneic
Autor:
Dirk W. van Bekkum, H.M. Vriesendorp, Chris Zurcher, Peter J. Heidt, Willem M. Klapwyk, Ben Hogeweg
Publikováno v:
Tissue Antigens. 20:63-80
The LD50 of total body irradiation (TBI) for the bone marrow (BM) syndrome and the gastrointestinal (GI) syndrome was determined in dogs as 3.7 Gy, and 8.5 Gy respectively. Five Gy TBI was adequate conditioning for BM cells of littermate donors ident
Publikováno v:
Radiotherapy and Oncology. 23:160-169
Rats receiving lethal irradiation to their exteriorized small intestine with pulsed 18 MVp bremsstrahlung radiation live about 4 days longer than rats receiving a dose of total-body irradiation (TBI) causing intestinal death. The LD50 for intestinal
Autor:
H.M. Vriesendorp
Publikováno v:
Radiotherapy and Oncology. 18:37-50
Total body irradiation (TBI) is an important but toxic element in the preparation of patients for bone marrow transplantation. TBI can be delivered in many different ways and analysed for many different endpoints. The published clinical and large ani
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 20:635-637
Early analyses of the effects of “accidental” Total Body Irradiation (TBI) led to the discovery of the possibilities of bone marrow transplantation (4-6). The logical consequence of these new insights was the design of treatment protocols in whic
Autor:
Jerry L. Klein, R.L. Stinson, Peter K. Leichner, Jerry R. Williams, O.C. Onyekwere, Syed M. Quadri, H.M. Vriesendorp, Y. Shag
Publikováno v:
International journal of radiation oncology, biology, physics. 22(1)
Promising response rates are noted in patients with refractory Hodgkin's disease after radioimmunoglobulin therapy (RIT) with Yttrium-90 labeled polyclonal antiferritin. To explore the most efficacious selection of RIT reagents for use in humans, exp
Autor:
J M Herpst, H.M. Vriesendorp, Peter K. Leichner, Jerry L. Klein, M A Germack, D M Loudenslager, Stanley E. Order
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 9(6)
Radiolabeled antiferritin immunoglobulin (Ig) preparations were tested in patients with advanced, end-stage Hodgkin's disease. Four patients received indium-111 (111In)-labeled monoclonal antiferritin (QCI). Targeting was not observed in tumor-bearin
Autor:
H.M. Vriesendorp
Publikováno v:
Critical reviews in oncology/hematology. 10(3)
Unexpected total body irradiation (TBI) of human beings, involved in nuclear warfare or in accidents in nuclear reactors can be lethal. In the 1950s, bone marrow transplantation was discovered as a potentially life saving procedure after TBI in the d
Autor:
X. Z. Tang, Syed M. Quadri, S. Wang, H.M. Vriesendorp, Lollo Cp, R. M. Bartholomew, L. C. Stephens
Publikováno v:
Radiation Research. 141:294
High-dose radiation therapy for liver metastases of gastrointestinal malignancies might be improved by combining external-beam irradiation and radioimmunoglobulin therapy. We studied the liver toxicity of the proposed combination in healthy beagle do
Autor:
A. Siddiqui, Bill F. Byrd, Jay A. Harolds, H.M. Vriesendorp, J. L. Klein, S. M. Quadri, Sara Powell, Ronald C. Walker, Milton J. Guiberteau, Jerry R. Williams, Deborah Havens, Scott Young, Robert J. Telepak, Angelita Ramos-Gabatin, Jack L. Lancaster, Debra Savory, Richard S. Rome, Ramesh D. Dhekne
Publikováno v:
Clinical Nuclear Medicine. 19:265